Abbott Laboratories shares owned by Moloney Securities Asset Management
Quarter-by-quarter ownership of Abbott Laboratories (ABT) shares owned by Moloney Securities Asset Management
from 13F filings
Historical chart of Moloney Securities Asset Management investment in Abbott Laboratories
Tip: Access up to 7 years of quarterly data
All positions including Abbott Laboratories held by Moloney Securities Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abbott Laboratories by Moloney Securities Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.0M | 15k | 133.94 |
| 2025-06-30 | $2.1M | 16k | 136.01 |
| 2025-03-31 | $2.1M | 16k | 132.65 |
| 2024-12-31 | $2.2M | 19k | 113.11 |
| 2024-09-30 | $2.3M | 20k | 114.01 |
| 2024-06-30 | $2.1M | 21k | 103.91 |
| 2024-03-31 | $2.6M | 23k | 113.66 |
| 2023-12-31 | $2.6M | 24k | 110.07 |
| 2023-09-30 | $2.3M | 24k | 96.85 |
| 2023-06-30 | $2.5M | 23k | 109.02 |
| 2023-03-31 | $2.3M | 22k | 101.26 |
| 2022-12-31 | $2.5M | 23k | 109.79 |
| 2022-09-30 | $2.3M | 24k | 96.76 |
| 2022-06-30 | $2.6M | 24k | 108.65 |
| 2022-03-31 | $2.8M | 24k | 118.35 |
| 2021-12-31 | $3.4M | 24k | 140.72 |
| 2021-09-30 | $3.1M | 27k | 118.14 |
| 2021-06-30 | $3.5M | 30k | 115.93 |
| 2021-03-31 | $3.8M | 32k | 119.83 |
| 2020-12-31 | $3.4M | 32k | 109.50 |
| 2020-09-30 | $3.6M | 34k | 108.84 |
| 2020-06-30 | $3.2M | 35k | 91.43 |
| 2020-03-31 | $2.3M | 30k | 78.91 |
| 2019-12-31 | $2.6M | 30k | 86.87 |
| 2019-09-30 | $2.6M | 31k | 83.66 |
| 2019-06-30 | $2.9M | 34k | 84.10 |
| 2019-03-31 | $2.9M | 37k | 79.94 |
| 2018-12-31 | $2.7M | 37k | 72.32 |
| 2018-09-30 | $2.8M | 38k | 73.36 |
| 2018-06-30 | $2.3M | 38k | 60.99 |
| 2018-03-31 | $2.3M | 38k | 59.93 |
| 2017-12-31 | $2.1M | 37k | 57.08 |
| 2017-09-30 | $2.1M | 39k | 53.35 |
| 2017-06-30 | $1.3M | 27k | 48.60 |
| 2017-03-31 | $1.2M | 26k | 44.41 |
| 2016-12-31 | $951k | 25k | 38.40 |
More positions owned by Moloney Securities Asset Management
View all positions for Moloney Securities Asset Management